Latest Spirometry Stories

As CDC announces significant increases in flu activity in the US, indicating that an early flu season is underway, more people with chronic respiratory conditions are using Spiro PD Personal Spirometer to monitor their lung health. For more information, visit http://www.SpiroPD.com. Allentown, PA (PRWEB) December 11, 2012 The CDC has recently warned that the flu season is off to the earliest start in a decade, and that it could be severe. In order to protect their lung health, more people...

The website is designed to help doctors understand the importance of incorporating spirometry into their practice. Lewiston, ME (PRWEB) December 02, 2012 MD Spiro, a Micro Direct company, proudly announces the launch of their new spirometry eCommerce website platform for doctors and their practice. MD Spiro specializes in the sale and support of pulmonary diagnostic medical device products and can now sell direct to a doctor’s practice any time of the day. The website is designed to...

TOKYO, October 25, 2012 /PRNewswire/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) confirms the information released today by Novartis that QVA149, (indacaterol maleate / glycopyrronium bromide) an investigational drug for chronic obstructive pulmonary disease (COPD) has been filed for marketing authorisation with the European Medicines Agency (EMA), triggering a $5 million milestone payment to Sosei. The first five studies in the Phase III IGNITE...

MCLEAN, Va., Oct. 24, 2012 /PRNewswire-USNewswire/ -- On Sunday, Oct. 28, more than 40,000 runners will race in the Marine Corps Marathon in Washington, DC; however, Team AANMA defies the odds. Twenty-eight runners from across the United States will prove their fitness, perseverance and resolve - their AIR POWER - racing in support of Allergy & Asthma Network Mothers of Asthmatics (AANMA). "I was told as a child not to play any sports because of my asthma," says Team AANMA's...

CT scan technique developed at U-M can differentiate types of lung damage A new approach to lung scanning could improve the diagnosis and treatment of a lung disease that affects approximately 24 million Americans and is the country's third-highest cause of death. In a new paper published online in Nature Medicine, a team from the University of Michigan Medical School reports on a technique called parametric response mapping, or PRM. They used PRM to analyze computed tomography, or CT,...

RIDGEFIELD, Conn., Sept. 26, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose. There are no approved treatments in the U.S. for IPF, a progressive and severely debilitating lung disease with a high...

Lee Rannals for redOrbit.com - Your Universe Online As part of an increasingly popular trend toward health-focused smartphone applications, a new iPhone app allows people to measure their lung function directly through their smartphones. Researchers at the University of Washington, UW Medicine and Seattle Children's Hospital developed the application to allow people to monitor their lung function at home or on the go by simply blowing into their phone. Typically, people who suffer...

Ongoing series of webinars featuring healthcare professionals and patients address the challenges faced by people with lung disease. PMD Healthcare manufactures Spiro PD, the world’s first truly personal spirometer. For more information, visit http://www.SpiroPD.com. Allentown, PA (PRWEB) September 18, 2012 PMD Healthcare is conducting a series of free webinars to help educate and empower people with lung diseases – asthma, chronic obstructive pulmonary disease (COPD), bronchitis,...

VIENNA, Sept. 3, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) announced that new analyses of data from the RECAP extension study of Esbriet® (pirfenidone) were presented today at the 2012 Annual Congress of the European Respiratory Society (ERS) in Vienna, Austria by Dr. Ulrich Costabel of the Ruhrlandklinik, Essen, Germany. (Logo: http://photos.prnewswire.com/prnh/20120827/SF62570LOGO) The RECAP study is an ongoing open-label extension study evaluating the long-term...

BRISBANE, Calif., Aug. 27, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that an oral presentation and three poster presentations related to the company's research programs in idiopathic pulmonary fibrosis (IPF) will be presented at the Annual Congress of the European Respiratory Society (ERS) being held in Vienna, Austria, September 1-5. (Logo: http://photos.prnewswire.com/prnh/20120827/SF62570LOGO) New analyses of FVC change and Survival from the RECAP...